diabeedi

Diabeedi is a chronic metabolic disorder characterized by elevated blood glucose that results from defects in insulin production, action, or both.

The major forms are type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 1 is an autoimmune condition in which the pancreas fails to produce insulin. Type 2 involves insulin resistance with an insufficient insulin response. Gestational diabetes develops during pregnancy and usually resolves after delivery. Additional rare types are caused by genetic disorders, diseases of the pancreas, or certain medications.

Diagnosis relies on blood glucose testing and assessment of long-term glucose control. Common criteria include fasting plasma glucose, an oral glucose tolerance test, or an elevated HbA1c. Regular screening and risk factor assessment are recommended for at-risk populations.

Management focuses on maintaining blood glucose levels within target ranges to prevent complications. This typically includes lifestyle measures such as healthy eating, weight management, and physical activity; self-monitoring of glucose; and pharmacotherapy. Type 1 diabetes requires insulin therapy; type 2 diabetes may be managed with oral agents, non-insulin injectables, and often insulin as the disease progresses.

Common long-term complications affect the heart and blood vessels, kidneys, nerves, eyes, and feet. Early diagnosis and consistent care reduce risk. Public health efforts emphasize prevention for type 2 and education for patients.

From a global perspective, diabeedi is a leading cause of disability and death worldwide due to its complications, and prevalence continues to rise with aging populations and lifestyle changes.